Stay updated on Talimogene Laherparepvec and Nivolumab Combination Clinical Trial

Sign up to get notified when there's something new on the Talimogene Laherparepvec and Nivolumab Combination Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talimogene Laherparepvec and Nivolumab Combination Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:45:37.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value of Last Update Posted (Estimated) has been updated to Last Update Posted. This change indicates that the information regarding the last update of the study record is now confirmed and no longer an estimate.
    Difference
    0.0%
    Check dated 2024-06-10T19:27:52.000Z thumbnail image
  7. Check
    9 days ago
    Change Detected
    Summary
    The value 2024-06-05 2024-06-01 2024-06-01 2024-06-04 Last Update Posted has recently changed to 2024-06-07 2025-09-01 2025-09-01 2024-06-06 Last Update Posted (Estimated) 2024-06-07 2024-06. This change represents an update in the last posted update dates for the study record, indicating new information or modifications to the study details.
    Difference
    0.5%
    Check dated 2024-06-07T16:22:31.000Z thumbnail image
  8. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from '03 21 Adenoid Cystic Skin Adnexal Carcinoma Negative Anaplastic Large Cell Lymphoma, ALK-Positive 03 20 03 21 7' to '06 05 Adnexal Anaplastic Large Cell Lymphoma, ALK-Negative Positive Apocrine Carcinoma 06 04 06 05 8'. This change represents an update in the description of the medical conditions being studied in the clinical trial, specifically focusing on different types of skin cancers and lymphomas with varying characteristics.
    Difference
    0.9%
    Check dated 2024-06-06T14:40:01.000Z thumbnail image
  9. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide detailed eligibility criteria for participants, including specific health conditions and prior treatments required for inclusion in the study. This change offers more comprehensive information about the types of patients researchers are looking for, replacing the previous lack of information.
    Difference
    54%
    Check dated 2024-05-22T21:15:18.000Z thumbnail image
  10. Check
    46 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2024-04-30T21:53:46.000Z thumbnail image

Stay in the know with updates to Talimogene Laherparepvec and Nivolumab Combination Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talimogene Laherparepvec and Nivolumab Combination Clinical Trial page.